280 related articles for article (PubMed ID: 9506436)
1. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2.
Zone JJ; Taylor TB; Meyer LJ; Petersen MJ
J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436
[TBL] [Abstract][Full Text] [Related]
2. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain.
Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788
[TBL] [Abstract][Full Text] [Related]
3. 97 kDa linear IgA bullous dermatosis antigen localizes in the lamina lucida between the NC16A and carboxyl terminal domains of the 180 kDa bullous pemphigoid antigen.
Ishiko A; Shimizu H; Masunaga T; Yancey KB; Giudice GJ; Zone JJ; Nishikawa T
J Invest Dermatol; 1998 Jul; 111(1):93-6. PubMed ID: 9665393
[TBL] [Abstract][Full Text] [Related]
4. Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens.
Ghohestani RF; Nicolas JF; Kanitakis J; Claudy A
J Invest Dermatol; 1997 Jun; 108(6):854-8. PubMed ID: 9182810
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
[TBL] [Abstract][Full Text] [Related]
6. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2.
Haase C; Büdinger L; Borradori L; Yee C; Merk HF; Yancey K; Hertl M
J Invest Dermatol; 1998 Mar; 110(3):282-6. PubMed ID: 9506450
[TBL] [Abstract][Full Text] [Related]
7. IgA antibodies recognizing LABD97 are predominantly IgA1 subclass.
Egan CA; Martineau MR; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
Acta Derm Venereol; 1999 Sep; 79(5):343-6. PubMed ID: 10494707
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
[TBL] [Abstract][Full Text] [Related]
9. Cloning of partial cDNA for mouse 180-kDa bullous pemphigoid antigen (BPAG2), a highly conserved collagenous protein of the cutaneous basement membrane zone.
Li K; Guidice GJ; Tamai K; Do HC; Sawamura D; Diaz LA; Uitto J
J Invest Dermatol; 1992 Sep; 99(3):258-63. PubMed ID: 1512460
[TBL] [Abstract][Full Text] [Related]
10. The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1.
Shimizu H; Takizawa Y; Pulkkinen L; Zone JJ; Matsumoto K; Saida T; Uitto J; Nishikawa T
J Invest Dermatol; 1998 Nov; 111(5):887-92. PubMed ID: 9804354
[TBL] [Abstract][Full Text] [Related]
11. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases.
Schumann H; Baetge J; Tasanen K; Wojnarowska F; Schäcke H; Zillikens D; Bruckner-Tuderman L
Am J Pathol; 2000 Feb; 156(2):685-95. PubMed ID: 10666397
[TBL] [Abstract][Full Text] [Related]
12. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.
Ishiko A; Shimizu H; Kikuchi A; Ebihara T; Hashimoto T; Nishikawa T
J Clin Invest; 1993 Apr; 91(4):1608-15. PubMed ID: 7682575
[TBL] [Abstract][Full Text] [Related]
13. The 97-kDa (LABD97) and 120-kDa (LAD-1) fragments of bullous pemphigoid antigen 180/type XVII collagen have different N-termini.
Hirako Y; Nishizawa Y; Sitaru C; Opitz A; Marcus K; Meyer HE; Butt E; Owaribe K; Zillikens D
J Invest Dermatol; 2003 Dec; 121(6):1554-6. PubMed ID: 14675210
[No Abstract] [Full Text] [Related]
14. IgG and IgA antibodies in linear IgA/IgG bullous dermatosis target the ectodomain of bullous pemphigoid antigen 2.
Hertl M; Büdinger L; Christophoridis S; Yancey KB; Borradori L
Br J Dermatol; 1999 Apr; 140(4):750-2. PubMed ID: 10233336
[No Abstract] [Full Text] [Related]
15. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
Ghohestani RF; Claudy A
Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
[No Abstract] [Full Text] [Related]
16. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.
Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA
Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718
[TBL] [Abstract][Full Text] [Related]
17. IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded by bullous pemphigoid antigen cDNA.
Rico MJ; Korman NJ; Stanley JR; Tanaka T; Hall RP
J Immunol; 1990 Dec; 145(11):3728-33. PubMed ID: 1700993
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans.
Olivry T; Dunston SM; Fahey M; Nguyen N; Marinkovich MP
Vet Pathol; 2000 Jul; 37(4):302-9. PubMed ID: 10896391
[TBL] [Abstract][Full Text] [Related]
19. IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain.
Egan CA; Reddy D; Nie Z; Taylor TB; Schmidt LA; Meyer LJ; Petersen MJ; Hashimoto T; Marinkovich MP; Zone JJ
J Invest Dermatol; 2001 Feb; 116(2):348-50. PubMed ID: 11180014
[No Abstract] [Full Text] [Related]
20. BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.
Zillikens D
Keio J Med; 2002 Mar; 51(1):21-8. PubMed ID: 11951375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]